Evaluating the effects of Adalimumab in patients with acute respiratory distress syndrome caused by COVID-19 : Evaluating the efficacy and safety of Adalimumab in patients with acute respiratory distress syndrome caused by COVID-19

Medienart:

Klinische Studie

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

WHO International Clinical Trials Registry Platform - (2020) vom: 30. Nov. Zur Gesamtaufnahme - year:2020

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: COVID-19 pneumonia. COVID-19, virus identified;U07.1
Phase: Phase 2/Phase 3
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2020-11-10, Last updated: 2022-11-24

ICTRP ID:

IRCT20151227025726N23

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO004989104